RE:RE:The position of PMX within VantiveYep ..,
.., I would add that the CG likely sees the merits in making OXiris and PMX a one-two punch in ICU's worldwide, except perhaps in the US ( at least not in the short-term as there are no RCTs on the horizon to oust PMX as the only (more accurately soon to be) FDA approved therapy))
On that last point, it's my opinion that, the lack of OXiris approval will drive up the use of PMX in the US ( read higher than expected revenues)
MM